Florida International University

FIU Digital Commons
All Faculty

1-1-2008

Cognitive performance and the thymus among
HIV-infected subjects receiving HAART
Maria J. Miguez-Burbano
Robert Stempel School of publicHealth & School of Medicine, FloridaInternational University

John E. Lewis
University of Miami

Jose Moreno
University of Miami

Joel Fishman
University of Miami

Follow this and additional works at: https://digitalcommons.fiu.edu/all_faculty
Recommended Citation
Miguez-Burbano, Maria J.; Lewis, John E.; Moreno, Jose; and Fishman, Joel, "Cognitive performance and the thymus among HIVinfected subjects receiving HAART" (2008). All Faculty. 7.
https://digitalcommons.fiu.edu/all_faculty/7

This work is brought to you for free and open access by FIU Digital Commons. It has been accepted for inclusion in All Faculty by an authorized
administrator of FIU Digital Commons. For more information, please contact dcc@fiu.edu.

ORIGINAL RESEARCH

Cognitive performance and the thymus among
HIV-infected subjects receiving HAART
Maria J Miguez-Burbano 1
John E Lewis 2
Jose Moreno 3
Joel Fishman 4
Robert Stempel School of public
Health & School of Medicine, Florida
International University, Miami, FL,
USA, 2Department of Psychiatry
and Behavioral Sciences, 3 Department
of Medicine, 4 Department
of Radiology, University of Miami
Miller School of Medicine, Miami, FL,
USA
1

Objective: To evaluate the impact of alcohol use, which is widespread in human
immunodeﬁciency virus (HIV)+ individuals, on highly active antiretroviral therapy (HAART)associated immune and cognitive improvements and the relationship between those two
responses.
Methods: In a case-control longitudinal study, thymic volume, cognition, and immune responses
were evaluated at baseline and after 6 months therapy in HIV+ and HIV- controls. Cognitive
performance was evaluated using the HIV Dementia Score (HDS) and the California Verbal
Learning Test (CVLT).
Results: Prior to HAART, thymic volume varied considerably from 2.7 to 29.3 cm 3
(11 ± 7.2 cm3). Thymic volume at baseline showed a signiﬁcantly inverse correlation with
the patient’s number of years of drinking (r2 = 0.207; p ⬍ 0.01), as well as HDS and the
CVLT scores in both HIV-infected (r2 = 0.37, p = 0.03) and noninfected (r2 = 0.8, p = 0.01).
HIV-infected individuals with a small thymic volume scored in the demented range, as
compared with those with a larger thymus (7 ± 2.7 vs. 12 ± 2.3, p = 0.005). After HAART,
light/moderate drinkers exhibited thymus size twice that of heavy drinkers (14.8 ± 10.4 vs.
6.9 ± 3.3 cm3).
Conclusions: HAART-associated increases of thymus volume appear to be negatively affected
by alcohol consumption and signiﬁcantly related to their cognitive status. This result could have
important clinical implications.
Keywords: thymus, CNS, immune, alcohol
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The human immunodeﬁciency virus (HIV) epidemic is a major international public health problem (WHO 2005). Although the primary target of this virus is the
immune system, neurological abnormalities are common in patients infected with
HIV (Bean 2001). The immune system and central nervous system (CNS), once
considered completely independent, have been demonstrated to be closely linked
(Dalakas et al 1986; Fabris et al 1988; Spangelo 1995; Antoniou et al 1997; Turrini
et al 1998; Savino and Dardenne 2000; Nishiyama 2001; Morale et al 2003; Cavalloti
et al 2005; Fleming et al 2005). Bidirectional communication between the brain and
the thymus has been described in numerous studies, in association with cytokines,
hormones, growth factors, and neurotransmitters (Fabris et al 1988; Antoniou et al
1997; Morale et al 2003; Cavalloti et al 2005). These factors enable the thymus,
which plays a critical role during highly active antiretroviral therapy (HAART)
reconstitution, to act at sites distant from it, and it inﬂuences the ontogenesis and
function of both the immune system and CNS. Unfortunately, its role has been
overlooked in terms of HIV disease. Therefore, the present study explored the role
of alcohol use in cognitive impairment and recuperation from HAART through its
impact on the thymus.
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Methods
Sampling
Participants aged 18 to 55 years, who had been diagnosed with
HIV and had been receiving a new antiretroviral regimen for
less than 10 weeks, were eligible to be enrolled in the Miami
Alcohol Research Care for HIV (MARCH) study. Brieﬂy,
MARCH is a longitudinal observational study to evaluate
the impact of alcohol use on health status of HIV-infected
individuals receiving HAART. Participants were recruited
from the University of Miami Miller School of Medicine
and Jackson Memorial clinics, where these individuals are
followed at regular intervals. Antiretroviral eligibility criteria
were as follows: HIV-infected subjects could be either 1) naïve
or 2) had prior exposure to antiretroviral therapy, but they
must have discontinued HAART for at least 6 weeks prior to
starting this new regimen. The HIV cohort was matched by
stratifying gender, age, and race with an HIV seronegative (as
per laboratory testing during the previous six months) community control, consisting of friends and relatives of enrolled
participants for comparing study outcomes.
Participants were divided into hazardous (Group 1) and
nonhazardous drinkers (Group 2), according to National Institute of Alcohol and Alcohol Abuse (NIAAA) and American
Association guidelines (Fleming 2005). Alcohol consumption
assessments included widely-used standardized and validated
brief screening questionnaires: Physician’s Guide (NIAAA)
(Fleming 2005), Cut, Annoyed, Guilty, Eye opener (CAGE),
Alcohol Use Disorder Identiﬁcation Test (AUDIT), and
Alcohol Dependence Scale (ADS). Men who reported ⬎14
and women ⬎7 or more drinks/week were enrolled in Group
1, while those who reported fewer drinks were included in
Group 2. Those who provided written informed consent and
medical release were enrolled. The Institutional Review Board
at the University of Miami approved the study.
Using standardized questionnaires, the following data
were collected: sociodemographic information, drugs, alcohol
use habits, and past and current medical history. HIV positives
were questioned with acquired immunodeﬁciency syndrome
(AIDS)-deﬁning Centers for Disease Control and Prevention
(CDC) criteria to establish HIV disease status. Medical prescriptions were documented and a standardized antiretroviral
adherence questionnaire administered. After visit procedures
were completed, a medical chart and pharmacy records were
abstracted and patient information was validated.

Immune assessments
Blood samples were collected from all participants and processed within 6 hours. Isolated peripheral blood mononuclear
322

cells were prepared for four-color direct immunoﬂuorecence
procedures (Becton Dickinson, San Jose, CA). Flow cytometry quantiﬁed the percentage and absolute numbers of
T lymphocyte sub populations CD3+/CD4+ and CD3+/CD8.
In addition, HIV viral burden was quantiﬁed using the Amplicor HIV monitor test (Roche Diagnostic System).

Thymus
Magnetic resonance (MR) imaging was selected over
computed tomography (CT) because MR provides superior
soft tissue contrast, and avoids the use of ionizing radiation
and contrast administration (De Geer et al 1986; Watzl
et al 1993). The MR was obtained only in a sub-sample of
patients that, were adherent to their prescribed medication
after the ﬁrst month. The MR was performed using a thoracic
surface coil and electrocardiographic gating, and consisted
of the following sequences: 1) Sagittal and coronal pilots;
2) T1-weighted axial, slice thickness 6 mm, interslice gap
1 mm, 4 averages; and 3) T2-weighted axial fat-suppressed,
slice thickness 6 mm, interslice gap 1 mm, 4 averages.
Thymic volume can be estimated from the sum of the areas
of manually drawn regions-of-interest from each image on
which glandular thymic tissue appears. However, the adult
thymus is generally fatty involuted, and calculations of true
glandular volume may be inaccurate if fatty elements are not
excluded. Therefore, we instead performed a quantitative
thymic volume calculation by measuring total mediastinal
area, mean mediastinal signal intensity (SI [mediastinum]),
fat signal intensity (SI [fat]), and muscle signal intensity (SI
[muscle]) on each T1 weighted slice. We assumed that pure
glandular (thymic) tissue would have a signal intensity similar to that of muscle, whereas a completely fatty involuted
thymus would have a signal intensity of fat. For each slice
from the left brachiocephalic vein superiorly to the main
pulmonary artery inferiorly, we then calculated thymic area
using the following formula:
Quantitative thymic area
= total mediastinal area *

SI(fat)−SI(mediastinum)
SI(fat)−SI(muscle)

The sum of thymic areas was then multiplied by the slice
thickness plus interslice gap (7 mm) to obtain total thymic
volume.

Cognition
The HIV Dementia Scale (HDS) was used as a valid screening tool with 10 as a cutoff point. The HDS had a sensitivity
of 80%, speciﬁcity 91%, and positive predictive value 78%
for identifying HIV dementia (Power et al 1995). The HDS
Biologics: Targets & Therapy 2008:2(2)
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was shown as superior to other widely used rapid screening tests (Mini-Mental State Examination). In addition, it
has been previously used to monitor therapeutic effects on
the CNS (Dougherty et al 2002). The HDS is comprised of
four tasks that evaluate the domains of memory, attention,
psychomotor speed, and construction.
The California Verbal Learning Test (CVLT) is a multidimensional measure of verbal learning and memory, which
includes two word lists, each of which contains 16 shopping
items (Delis et al 1987). Items are distributed according to a
Monday list and a Tuesday distracter list, with scores representing the number of objects that an individual can recall.
Participants are asked to recall the Monday list spontaneously,
following semantic cues and after a 20-minute delay. Finally,
participants are given a “yes/no” recognition test in which
they are presented with the 16 target words embedded within
a list of 28 nontarget words. Scores are based on the number
of words provided by the participant on the various trials and
on the number of times they correctly identify a word to be a
member or not of the ﬁrst list (Delis et al 1987).

Statistical analyses
The data were analyzed using SAS version 8 (SAS Institute
Inc., Cary, NC) and SPSS version 11 (SPSS Inc., Chicago,
IL) and p values ⬍0.05 were considered to be statistically
signiﬁcant. Following descriptive statistical analyses, mean
variables were compared using Student’s t-test and one-way
analysis of variance (ANOVA) procedures. Correlations
among the main variables of interest were examined with
Pearson’s coefﬁcients.
Logistic regression analyses were used to evaluate the
effects of alcohol, HAART, and other potential risk factors
on cognition. Univariate analyses were used to calculate odds
ratios (OR) and 95% conﬁdence intervals (CI).
To identify the pattern of change in cognitive status over
time and under the effect of HAART (no change, decrease, or
increase), differences in average scores between baseline and
second visit evaluation were assessed using t-tests for paired
samples and analyzed by thymus size and alcohol groups.
Finally, linear regression analyses were performed for
each comparison. Although no signiﬁcant differences were
observed between groups for education level or CDC status,
both variables were controlled for in the ﬁnal analyses.

Results
Study population characteristics
This longitudinal study assessed a multiethnic sample of
162 HIV-infected subjects, including 89 hazardous drinkers
Biologics: Targets & Therapy 2008:2(2)

and 73 nonhazardous drinkers. The 35 HIV seronegative
participants included 20 hazardous and 15 nonhazardous
drinkers. Participants ranged in age from 24 to 54 years (mean
40 ± 7 years). More than half (66%) of the participants were
male and 34% were female. Years of education varied across
the sample from 1–16 years (mean 11.4 ± 3 years) and 25%
had more than 12 years of education.
Approximately one-third of the participants acknowledged current drug abuse, particularly crack/cocaine and
marijuana.
The sample reported an average of 20 ± 2 drinks/week,
along with a well-documented history of continuous alcohol
consumption averaging 8 ± 7 drinks per day for more than
a month prior to sampling. Despite receiving HAART, the
HIV-infected group reported average weekly alcohol consumption similar to the seronegative individuals (22 ± 2.5 vs.
25 ± 4.3 drinks). No signiﬁcant difference in any of the
above mentioned characteristics was observed between HIV
seropositives and seronegatives.
The mean CD4 cell count of the total group was
255.3 ± 242.8. On average, the study sample had a viral
load of 227,899 ± 140,834 copies. Only half of the study
participants reported full adherence to their medication and
received a MR evaluation (Table 1).

Cognition
At baseline, 60% of HIV positives had total scores below
9 of 16 possible points, indicating dementia. No signiﬁcant
correlations were found between the HDS scores and age,
education, viral load, CD4, or drug use.
A signiﬁcant correlation was observed between total
drinks per week and mental status, as indicated by baseline
total HDS (r2 = 0.22, p = 0.003). The seronegative nonhazardous drinkers exhibited the highest HDS scores (12.5 ± 3.8),
followed by HIV-infected nonhazardous drinkers (10.4 ± 4),
HIV seronegative hazardous drinkers (8.6 ± 5 total score),
and those with dual co-morbidity (8.4 ± 3.7). No signiﬁcant

Table 1 Baseline characteristics of study population by alcohol
consumption
Characteristics

Nonhazardous
drinkers

Hazardous
drinkers

Number of individuals (%)
Number of women (%)
Mean (SD) age (years)
Education (SD) (years)
CD4 cell counts (SD)

73 (45)
20 (27.4)
40.7 (7.3)
11.0 (0.07)
253 (179)

89 (55)
35 (39.3)
40.5 (7.5)
11.8 (0.10)
256 (184)

Data are mean (SD) or numbers (%), unless otherwise indicated.
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effects of gender, age, or education were observed in HDS
total scores.
The correlation between alcohol drinks/week and HDS
score remained significant after six months of HAART
(r = 0.16, p = 0.02). Signiﬁcantly low mean HDS total
scores were noted in hazardous alcohol users, compared with
nonhazardous alcohol users (df = 162, F = 1.94; 9.2 ± 3.5 vs.
10.5 ± 3.8, p = 0.04). Moreover, all HIV-infected heavy alcohol users scored ⬍8 on the HDS. Univariate analyses indicate
that HIV-infected hazardous alcohol users were more likely
to have dementia compared with seronegative nondrinkers
(OR = 1.7, 95% CI: 1–2.38, p = 0.05). After HAART, paired
t-test analyses indicated no changes in total HDS scores in
either hazardous alcohol users or nonhazardous drinkers.
Negative correlations were evident between drinks/week
and both Monday (r2 = −0.21, p = 0.009) and Tuesday recalls
(r2 = −0.15, p = 0.04). No signiﬁcant correlations were found
between the CVLT and age, gender, level of education, or
drug use. Low mean Monday scores on the CVLT were evident in the seronegative nonhazardous drinkers, as compared
with the seronegative hazardous drinkers (df = 35, F = 1.18;
11.4 ± 2.9 vs. 10 ± 3.7, p = 0.04), and were also lower for
the Tuesday list (df = 35, 5 ± 2 vs. 7.6 ± 2.6, p = 0.003). The
groups also tended to differ in the long delay free recall test
(df = 35, 11.6 ± 3 vs 9.3 ± 4 words, p = 0.07). Low mean
scores on the CVLT were evident in HIV-infected hazardous
alcohol drinkers. Recall for both short and long delays was
poorer in HIV-infected hazardous alcohol drinkers (df = 162,
8 ± 3 and 9 ± 4 items, respectively) than in HIV-infected
nonhazardous alcohol drinkers (df = 162, 9.5 ± 3.7 items,
p = 0.05; 10 ± 4 words, p = 0.06; See Table 2.). Delay recognition scores were also signiﬁcantly worse in HIV-infected
hazardous alcohol drinkers than in HIV nonhazardous
drinkers (df = 162, F = 2.49; 10.5 ± 3.7 words vs. 12.8 ± 3.2
words, p = 0.03).
Statistically signiﬁcant improvement in short memory
tasks (change = 1–2 words) was evident after six months of

HAART in both hazardous alcohol drinkers (p = 0.001) and
nonhazardous alcohol drinkers (p = 0.001). The previous
observed difference in the HIV positive groups persisted at
the six-month evaluation. Hazardous alcohol drinkers were
twice as likely as nonhazardous alcohol drinkers to forget
more words (remember less than 10/15 words, 95% CI:
1–6.6; p = 0.04). Long delay free recall remained signiﬁcantly lower after HAART treatment in hazardous alcohol
drinkers, than in HIV-infected nonhazardous alcohol drinkers
(df = 162, F = 1.94; 8.8 ± 3 words vs. 10.4 ± 4; p = 0.03).
No signiﬁcant changes between baseline and six-month
evaluations were evident in any of the study parameters in
the noninfected group.

Baseline cognitive performance
according to immune parameters
Thymus size was signiﬁcantly correlated with total HDS
score (r2 = 0.5, p = 0.05) at baseline. Patients were separated
into those with thymus volumes above or below 13 cm3,
which corresponds to the mean volume of the HIV negative
control population. Participants with a small thymus scored
in the demented range (7 ± 2.7) compared with those with
a larger thymus (df = 87, F = 2.6; 12 ± 2.3, p = 0.005).
Importantly, a smaller thymus size was characteristic of
HIV-infected hazardous alcohol drinkers and none and/or no
signiﬁcant improvement in CD4 cell counts after 6 months
of treatment (Figure 1).
Thymus size was also correlated with the CVLT scores
in both HIV-infected (r2 = 0.37, p = 0.03) and noninfected

Table 2 Cognitive and immune baseline characteristics
Characteristics

Nonhazardous
drinkers

Hazardous
drinkers

HIV dementia scores (HDS)
CVLT short delay recall
CVLT long delay recall
Viral load
CD4 cell counts (SD)

10.4 ± 4
9.5 ± 4
10 ± 4
177, 810 ± 36, 290
253 ± 179

8.4 ± 4
8±3
9±4
233, 778 ± 35, 674
256 ± 184

Notes: Data are mean (SD) or numbers (%), unless otherwise indicated.
Abbreviations: HDS, HIV dementia scale; CVLT, California Verbal Learning Test.
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Figure 1 Axial T1 weighted image of the thymus of an antiretroviral treated
nonhazardous drinker.The thymus (arrow) is of intermediate signal intensity with small
amounts of higher intensity fat (arrowheads) around it.
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participants (r2 = 0.8, p = 0.01). Correlations between CVLT
scores and thymus size were generally highest among HIVinfected individuals. A positive, signiﬁcant correlation was
also noted between thymus size and the Monday recall
list (r2 = 0.4, p = 0.05). Univariate analyses indicated that
patients with a thymus size ⬎13 cm3 were 5 times more
likely to recall more than 8 words in the Monday list (95%
CI: 1.2–16.0, p = 0.02).
HIV-infected participants with more than 200 CD4 cell
counts exhibited similar total HDS (10.1 ± 3.9 vs. 9.4 ± 3.3)
and CVLT (11.7 ± 3.3 vs. 10.9 ± 2.6; p ⬎ 0.05) scores, as
compared with those with less than 200 CD4 cell counts.

After 6 months of HAART
After 6 months of HAART, thymus volumes increased an
average of 25% (5 ± 3 cm3). On average, nonhazardous
alcohol drinkers signiﬁcantly improved their CD4 by 20
cell counts (p = 0.04), which contrasted with only a 3 cell
improvement among the hazardous alcohol drinkers. Accordingly, those with a large thymus improved on average by 25
cell counts, while those with a small thymus lost 34 CD4+ cell
counts despite treatment. The sample sizes were insufﬁcient
to allow analyses by regimen type or by CNS penetration.
After HAART, a slight increase in mean HDS scores was
observed in all groups, except for the hazardous drinkers
with a small thymus. Nonhazardous drinkers with a larger
thymus after HAART exhibited the highest HDS scores
(13.8 ± 1.3), followed by nonhazardous drinkers with a
small thymus (11.6 ± 2.4), hazardous drinkers with a small

thymus (8.9 ± 5 total score), and those with dual co-morbidity
(7.4 ± 2.7). Longitudinal analyses indicated that participants
with a smaller thymus were twice as likely to score in the
demented range as those with a larger thymus (RR = 1.6,
95% CI: 1–2.3, p = 0.05).
Statistically signiﬁcant improvement in short memory
tasks (change = 1–2 words) was also evident in both hazardous alcohol drinkers (p = 0.001) and nonhazardous alcohol
drinkers (p = 0.001). The correlation between thymus size
and short-delay recall was even stronger (r2 = 0.6, p = 0.008)
after HAART. Thymus size also correlated with long delay
free recall (r2 = 0.7, p = 0.003). Additional analyses indicated
signiﬁcantly poorer recall scores in HIV seropositives with a
smaller thymus (short delay: 8.9 ± 2.4 words and long delay:
9.1 ± 2.6 words), compared with those with a normal size
thymus (13.6 ± 2.8 items, p = 0.01; 13 ± 3.4 words, p = 0.05;
See Table 3). After HAART, HIV-infected subjects with a
small thymus were still twice as likely as HIV positives with
⬎13 cm of thymus to remember fewer than 8 items in the
Monday list (95% CI: 1.1–4.4, p = 0.04). They were also
less likely to remember more than 5 items in the Tuesday
list (RR = 6, p = 0.03).
Patients that increased their thymus size after HAART
had significantly improved recall (Monday list change
2 ± 0.8, p = 0.03) and long delayed free recall (1.9 ± 0.6,
p = 0.01). In contrast, no signiﬁcant improvement in recall
was shown for those whose thymus failed to increase in size
(Monday 0.2 ± 0.1 and long delayed 0.4 ± 0.1).
In the ﬁnal analyses, age, CDC stage, alcohol consumption, education, and thymus size were included as dichotomous variables in the ﬁnal regression model with HDS as
the dependent variable. As illustrated in Table 4, hazardous
alcohol consumption (RR = 9; 95% CI: 1.0–98, p = 0.04) and
small thymus (RR = 7.5; 95% CI: 1.5–38, p = 0.01) were the
only variables associated with HIV dementia after adjusting
for potential confounders.

Table 3 Cognitive and immune measurements after 6 months of
HAART according to thymus size

Figure 2 Axial T1 weighted image of the thymus of an antiretroviral treated hazardous drinker. The mediastinum largely consists of high intensity fat, with a small
thymus (black arrow).
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Characteristics

Small thymus

Large thymus

p Value

HIV dementia scores
(HDS)
CVLT short delay recall
CVLT long delay recall
CD4 cell counts (SD)

8.0 ± 4.7

11.7 ± 3

0.03

8.9 ± 2.4
9.1 ± 2.6
−34 ± 7

13.6 ± 2.8
13 ± 3.4
25 ± 4

0.01
0.05
0.05

Data are mean (SD) or numbers (%), unless otherwise indicated.
Abbreviations: CVLT, California Verbal Learning Test; HAART, highly active antiretroviral therapy; HDS, HIV dementia scale; SD, standard deviation.
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Table 4 Odds ratios for dementia according to alcohol intake
Model

Univariate OR

95% CI

Multivariate OR

95% CI

Regression
Drinker
Thymus

1.23
1.6

1–4.1
1–2.3

9
7.5

1–98
1.5–38

Df

F

p Value

87

6.109

0.05
0.04
0.001

Abbreviations: OR, odds ratio; CI, Confidence interval.

Discussion
Until recently, it was thought that a close interaction between
the thymus and the CNS only occurred during development.
However, we have made a remarkable medical discovery in
humans. The thymus is closely related to cognitive status
in HIV-infected and noninfected adults. Furthermore,
additional analyses indicated that cognitive task restoration
following HAART administration is associated with thymus
regeneration and impacted by alcohol consumption.
Thymus size effects were evident at baseline in both HDS
and CVLT tests and observed in both HIV-infected and noninfected participants. Notably, correlations were generally
highest among HIV-infected individuals and related to the
deleterious effects of alcohol and HIV in these individuals.
These ﬁndings conﬁrm and extend previous animal studies
that have found a signiﬁcant relationship between cognitive
and CNS structural changes and thymus (Song and Bao 1991;
Saito et al 1994; Zhang et al 1994; Wang and Spitzer 1997).
Athymic mice and thymectomized rats have been reported
to exhibit memory impairment in spatial and conditioned
memory. Alterations in learning performance have been consistently observed at 3, 5, and 10 months post-thymectomy,
suggesting that the thymus signiﬁcantly inﬂuenced learning
and memory ability (Song and Bao 1991; Saito et al 1994;
Zhang et al 1994; Wang and Spitzer 1997; Nishiyama 2001).
The operation also results in an underdeveloped brain with a
thin cortex and changes in learning performance. However,
if the thymus is re-implanted, the frontal area becomes as
thick as normal (Song and Bao 1991; Saito et al 1994; Zhang
et al 1994; Wang and Spitzer 1997). These ﬁndings are of
particular relevance to our study, as neuropsychological
disturbances associated with HIV-1 infection are consistent
with dysfunction of frontal-subcortical circuitry (Meyerhoff
2001). Cytokines, prolactin, and thymosins are some of
many candidates for the role of messengers mediating thymus induction of cognitive and psychobehavioral disorders
(Fabris et al 1988; Song and Bao 1991; Saito et al 1994;
Zhang et al 1994; Spangelo 1995; Antoniou et al 1997; Wang
and Spitzer 1997; Turrini et al 1998; Savino and Dardenne
2000; Nishiyama 2001; Morale et al 2003; Cavalloti et al
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2005). These ﬁndings conﬁrm that our results have solid
physiopathological reasons and represent more than a fortuitous association.
In line with this notion, our data also indicate for the
ﬁrst time that alcohol-induced impaired mental status in
HIV positive subjects is, at least in part, mediated by its
effects over the thymus. Findings indicated that thymus
atrophy is more evident in hazardous alcohol users and that
the deleterious effect on the thymus impacts learning and
memory ability. This is in accord with publications in the
1980s and early 1990s that alcohol use affects the size and
weight of the thymus in animal models and in infants exposed
to alcohol in utero (Song and Bao 1991; Saito et al 1994;
Zhang et al 1994; Wang and Spitzer 1997). Potential mechanisms mediating alcohol-induced thymic alterations include
apoptotic changes, impaired mitochondrial function, and
decreased total glutathione and antioxidant concentrations
in thymocytes (Song and Bao 1991; Saito et al 1994; Zhang
et al 1994; Wang and Spitzer 1997). Possible interactive
effects of ethanol and HIV infection in the CNS have been
explored through studies of oxidative stress and interleukins.
Findings from these studies reveal that both alcohol and
HIV may increase oxidative stress in the brain and produce
pro-inﬂammatory and TH2 interleukins (Meyerhoff 2001).
These results are of relevance to our ﬁndings, as the thymus
regulates a number of the interleukins and thymic hormones,
which have been demonstrated to reduce damage induced by
oxidative stress in the CNS (Fabris et al 1988; Song and Bao
1991; Saito et al 1994; Zhang et al 1994; Wang and Spitzer
1997; Spangelo 1995; Antoniou et al 1997; Turrini et al 1998;
Savino and Dardenne 2000; Nishiyama 2001; Morale et al
2003; Cavalloti et al 2005).
Before HAART, patients with HIV-associated dementia
(HAD) typically experienced rapid deterioration over a few
months (Suarez et al 2001; McArthur et al 2005). HAART
has played a major role in modifying the course of HAD
(McArthur et al 2005). Encouragingly, our data, along with
others, indicate some improvements in neuropsychological test performance abnormalities after starting HAART,
but progress is not observed in all participants who were
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receiving and maintained adherence to HAART (McArthur
et al 2005). The mechanism hindering HAART’s beneﬁcial
responses in some subjects, but not in others, remains largely
unclear (McArthur et al 2005). Of interest, improvements in
cognitive tasks after 6 months of HAART in our study were
not associated with viral loads, CD4 counts, or age, but rather
with thymus restoration, which is undermined by alcohol
consumption. These ﬁndings further conﬁrm our hypothesis
regarding the role of thymus in the CNS.
Although the HDS and the CVLT cannot solely determine
the presence of dementia in HIV-infected subjects, study
participants were limited to those followed at University of
Miami facilities, and MR was obtained only in a sub-sample
of participants, our ﬁndings do illustrate the relationship
between the thymus and neuropsychological functioning in
both HIV disease and alcohol abuse, which was overlooked
until now. These exciting results have improved understanding
of the neuro-immune systems. The ﬁndings reported here
should be tested with a comprehensive cognitive battery and,
if supported by further studies, may have important clinical
and therapeutic implications for neuroimmune diseases, when
considering that several pathways manipulate the thymus and
thymus-related substances.
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